Fishawack Health welcomes Mario Muredda as its new President of Marketing
February 2, 2023 | Marketing, Pharma, biopharmaceutical, healthcare, medical technology, omnichannel, wellness
Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.
Knutsford, UK, February 2, 2023—Mario Muredda joins Fishawack Health (FH) as its new President of Marketing. He will unite FH’s Global and North American teams in a new period of growth designed to further enhance the commercialization partner’s data-driven and omnichannel marketing offering for its biopharmaceutical, medical technology, and wellness clients.
“I am thrilled to join FH at such an important time for the organization,” says Muredda. “The company has brought together a truly special and unique offering—a connected group of professionals who can drive end-to-end commercialization success for our partners in health. Everyone I’ve met has been so warm, welcoming, and inspired. The team’s energy is contagious. I’m excited to become part of a company whose foundational belief is ‘better health happens when we connect’. Our teams are helping clients make important connections happen every day—with healthcare professionals, patients, caregivers, and advocacy groups.”
A veteran in pharmaceutical marketing and a people-first leader, Muredda joins the company after most recently serving as CEO at Harrison and Star. He brings a wealth of experience leading healthcare marketing agencies with a focus on combining data, creativity, science, and strategy to deliver solutions that improve health outcomes.
In his new role at FH, Muredda will lead the company’s marketing strategies and solutions to meet and surpass clients’ needs and the needs of their stakeholders, orchestrating connected and personalized experiences that blend scientific knowledge and strategic creativity.
Muredda will report to Gail Flockhart, Chief Commercial Officer (CCO). Jas Hummel will continue as Head of Global Marketing and Chief Sales and Marketing Officer. Together, Muredda and Hummel are leading a team of more than 600 healthcare specialists in creative, strategic, scientific, technology, data, production, project management, and client management, bringing these teams together to ensure FH’s clients benefit from globe-spanning healthcare marketing expertise.
Further expanding its Marketing leadership in the UK, FH also welcomed Elly Price as Managing Director of Global Marketing. Price will report to Hummel, bolstering FH’s strong client relationships to ensure brands drive greater connections with their stakeholders through exceptional marketing. Building on her operating philosophy which equates collaboration with success, she will empower FH’s Global Marketing team to generate new ideas, harnessing their skills in strategy and creativity to deliver results for their clients and the wider business. Having previously worked in senior leadership roles at Grey Healthcare Group, Price brings more than 25 years of experience in pharmaceutical marketing and deep expertise across a wealth of therapeutic areas.
The Marketing discipline is an integral part of FH’s interdisciplinary offering in which the organization’s Medical; Marketing; Policy; Value, Evidence, and Access; and Consulting disciplines collaborate in bespoke teams. This approach empowers the teams to bring a variety of lenses to meet each client’s commercialization needs, breaking down silos and accelerating the development of novel solutions.
“Mario and Elly join us at an exciting time in the evolution of our Marketing offering at FH as we bring together our foundational expertise in science, analytics, creative, and digital technology to create brands that are intelligently dynamic, stay relevant, and provide growth by improving people’s health,” says Flockhart. “During the past year, FH has continued to attract impressive healthcare marketing talent and garnered terrific feedback from our clients, which is a testament to our team members’ exceptional expertise. By further uniting our global and North American offerings, we can more effectively and efficiently deliver as an analytics-driven brand agency of record for our clients and a growing and interconnected network of stakeholders spanning healthcare professional, patient, caregiver, and consumer audiences.”
Muredda’s passion for making a difference is exhibited through his position on the board of the Dream Foundation, the only national dream-granting organization serving terminally ill adults and their families by helping fulfill end-of-life dreams. This work complements FH’s philanthropy initiatives in which its teams across the globe are encouraged and supported by the organization to give back to local communities.
Muredda is based in New York and Price is based in London, but both will work with teams across FH’s 20 locations spanning North America, Europe, and Asia.
About Fishawack Health
Established in 2001, Fishawack Health (FH) is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Our 1,500+ experts combine their knowledge and expertise across our core disciplines—Medical; Marketing; Policy; Value, Evidence, and Access; and Consulting—to create the connections that make better health happen.
We partner with our clients to navigate the complex and rapidly changing healthcare ecosystem. Together, we realize the potential of strategies and solutions to bring innovation to the hands of those who can benefit from it.
Visit us at Fishawack.com and follow us on Twitter and LinkedIn.
CONTACT INFORMATION
Global
Natasha Cowan
Senior Corporate Communications Manager
North America
Liz Mitchell
VP, US Marketing
elizabeth.mitchell@fishawack.com
+1 312 640 3700
This content was provided by Avalere Health
Company Details
Latest Content from Avalere Health
Avalere Health appoints new President of Medical to lead a tech-enabled future of medical affairs
Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.
Fishawack Health becomes Avalere Health, uncovering the potential in every product and the possibilities for every patient
As a single united organization, the company seamlessly connects science and creativity, technology and data, and ability and agility to ensure patients receive life-changing innovations faster.
Industry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilities
As Chief Operating Officer, Amar will unite global teams to drive innovation, enhance client solutions, and accelerate growth.
Fishawack Health appoints Chief People Officer to spearhead integration of talent and culture across geographies
Fishawack Health welcomes Harriet Shurville to the team as Chief People Officer to spearhead integration efforts, champion diversity and inclusion, and cultivate an environment where interdisciplinary teams thrive.
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer
Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.
Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...
The challenges of reimbursement and innovative pricing for cell and gene therapies
Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of...
Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes
Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech...
Fishawack Health welcomes Mario Muredda as its new President of Marketing
Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.